Home > GAMMAGARD Products > GAMMAGARD LIQUID SC > Protection

GAMMAGARD LIQUID - SC Administration

Protecting life’s moments with sustained protection against infection1,2

In the SC administration of GAMMAGARD LIQUID clinical study:

infection-related hospitalizations per subject per year

annual rate of acute serious bacterial infections per subject per yeara

  • 3 serious validated bacterial pneumonia cases

days of missed work/school or days unable to perform normal activities per subject per year

  • Total number of subject years was 44

aThe upper 99% confidence limit of 0.133 is substantially lower than the minimal goal of achieving a rate of <1 bacterial infection per subject per year.

Subject Discontinuations in the Clinical Study2

  • One subject withdrew from the study after 10 treatments with GAMMAGARD LIQUID subcutaneous infusion (2.5 months) due to increased fatigue and malaise

References: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information]. Westlake Village, CA: Baxter Healthcare Corporation. April 2014. 2. Wasserman RL, Melamed I, Kobrynski L, et al. Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease. J Clin Immunol. 2011;31:323-331.

  • Your patients can get access to experienced Patient and Nurse Advocates, insurance and financial support, useful tools, and more.
    Find Out How
  • Clinical Study Video Learn more about the clinical study of the subcutaneous administration of GAMMAGARD LIQUID.
    View study presentation

You are now leaving GAMMAGARD.com

Shire is not responsible for the privacy policy, the content or the accuracy of any web site accessed through a link on the GAMMAGARD.com site. A link to other web sites does not constitute an endorsement of Shire of the linked site, its products or services.

The browser window or tab for GAMMAGARD.com will remain open underneath the new browser window or tab. To return to GAMMAGARD.com at any time, close this tab or window.

Return to